Tuesday, 6 May 2014
INDIAN BENCHMARK have a subdued opening in wake of the negative cues from the global front. Shasun Pharma extends rally on acquiring global rights of Ibuprofen, Nuprin.
FURTHER, Titan is trading higher by 2% extending its previous day's 3.4% gain, after reporting 11.6% year-on-year (yoy) jump in net profit at Rs 206 crore for the fourth quarter ended March 31, 2014. HCL Technologies and DNB Bank announces US$ 400 mn strategic engagement.
Trend in FII flows: The FIIs were net buyers of Rs 45cr in the cash segment on Tuesday while the domestic institutional investors (DIIs) were net sellers of Rs. 55cr, as per the provisional figures released by the NSE.
http://www.capitalstars.com/stockcash.php
